AK
Arvind Kumar Srivastava
About Arvind Kumar Srivastava
Data last updated:
Arvind Kumar Srivastava is a Director at Granus Pharmaceuticals Private Limited (since 2016) and Designated Partner at Recyclo Biomedical Waste Products Llp (since 2017). The companies operate in Chemicals and Recycling & Waste Management. The largest current company by reported revenue is Granus Pharmaceuticals Private Limited at ₹27 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Granus Pharmaceuticals Private Limited U51507UP2016PTC084012 | Director | 14 Jun 2016 | 2016 | ₹27 Lakh (FY 2025) | Active |
| Designated Partner | 10 Aug 2017 | 2017 | Active |
Board colleagues of Arvind Kumar Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandrark Pandey | 07542977 | Granus Pharmaceuticals Private Limited | Director |
| Abhay Kumar Srivastava | 01304902 | Recyclo Biomedical Waste Products Llp | Designated Partner |
| Reema Barat | 07788649 | Recyclo Biomedical Waste Products Llp | Designated Partner |
| Thakur Bharat Srivastava | 07170062 | Recyclo Biomedical Waste Products Llp | Designated Partner |
| Trilok Ranjan Srivastava | 02166475 | Recyclo Biomedical Waste Products Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arvind Kumar Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arvind Kumar Srivastava
Arvind Kumar Srivastava currently holds 2 directorships: Granus Pharmaceuticals Private Limited (Director, since 14 Jun 2016, revenue ₹27 Lakh (FY 2025)); Recyclo Biomedical Waste Products Llp (Designated Partner, since 10 Aug 2017).
Arvind Kumar Srivastava was first appointed on 14 Jun 2016 as Director at Granus Pharmaceuticals Private Limited. The most recent appointment on record is 10 Aug 2017 at Recyclo Biomedical Waste Products Llp.
The current boards of Arvind Kumar Srivastava's companies include Chandrark Pandey (Granus Pharmaceuticals Private Limited), Abhay Kumar Srivastava (Recyclo Biomedical Waste Products Llp), Reema Barat (Recyclo Biomedical Waste Products Llp), Thakur Bharat Srivastava (Recyclo Biomedical Waste Products Llp), Trilok Ranjan Srivastava (Recyclo Biomedical Waste Products Llp).